ONCOLOGIX TECH, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0002 USD | 0.00% |
|
0.00% | -92.00% |
| 2022 | DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction. | CI |
| 2016 | Oncologix Tech, Inc. Announces Management Changes | CI |
Business Summary
Number of employees: 191
Sales per Business
| USD in Million | 2016 | Weight | 2017 | Weight | Delta |
|---|---|---|---|---|---|
Personal Care
97.6
%
| 3 | 75.5 % | 3 | 97.6 % | -8.21% |
Medical Products
2.4
%
| 1 | 24.5 % | 0 | 2.4 % | -93.06% |
Sales per region
| USD in Million | 2016 | Weight | 2017 | Weight | Delta |
|---|---|---|---|---|---|
North America
100.0
%
| 4 | 100.0 % | 3 | 100.0 % | -28.96% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 21-06-24 |
Nikole Jessie
IRO | Public Communications Contact | - | 15-05-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 21-06-24 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 1,662,469,227 | 1,645,844,535 ( 99.00 %) | 0 | 99.00 % |
| Stock B | 0 | 100,000 | 0 | 0 |
Company contact information
Sales per Business
| 1st Jan change | Capi. | |
|---|---|---|
| -92.00% | 332K | |
| +198.00% | 7.13B | |
| +2.19% | 982M | |
| +41.91% | 872M | |
| +25.43% | 820M | |
| +1.77% | 664M | |
| +5.92% | 648M | |
| -.--% | 600M | |
| +3.61% | 503M | |
| -.--% | 500M |
- Stock Market
- Equities
- OCLG Stock
- Company Oncologix Tech, Inc.